The Angioplasty Balloon market size was USD 2.66 Billion in 2023 and is expected to reach USD 3.58 Billion by 2032 and grow at a CAGR of 3.36% over the forecast period of 2024-2032.
This report offers thorough insights regarding the cost analysis and pricing trends, further showcasing variations in raw material costs, along with their impact on the market. The report studies adoption of latest innovations and technology, which boosts product advancements and operational efficiency. The report also covers compliance and regulatory statistics and further provide a clear view of government policies boosting the market growth.
Additionally, the report also presents mapping investments, statistics related to healthcare infrastructure, technological upgrades, and facility expansions globally. Together, these insights deliver a comprehensive understanding of market dynamics, challenges, and growth opportunities. The report also provides actionable intelligence to make strategic decisions.
The U.S. held the largest market share for angioplasty balloons in 2023, with a market size of USD 0.83 Billion. The market is projected to reach valuation of USD 1.15 Billion by 2032, expanding at a CAGR of 3.69% during the forecast period.
The country's growth is attributed to the advanced healthcare infrastructure, strong innovative medical technologies adoption, and high prevalence of cardiovascular diseases. According to study from the U.S. Centers for Disease Control and Prevention (CDC), heart disease is the leading cause of deaths in the U.S., with around 695,000 deaths in 2021 alone, which further generated a substantial demand for effective cardiovascular treatments in the U.S., including angioplasty. The well-established network of hospitals and specialty cardiac centers in the U.S. ensures wide access to minimally invasive procedures, such as the utilization of angioplasty balloons.
Furthermore, substantial healthcare spending, strong reimbursement policies, and presence of well-established medical device companies that actively engaged in producing next-generation angioplasty balloons further propel market expansion. surging awareness regarding early diagnosis and the advanced drug-coated and specialty balloons adoption also support the dominance of the U.S. in the global angioplasty balloon market.
Drivers
Increasing prevalence of cardiovascular diseases and rising geriatric population drive the angioplasty balloon market growth.
The growing prevalence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, is a major driver of the angioplasty balloon market. As per the World Health Organization (WHO), cardiovascular diseases are the major causes of death globally, that are responsible for more than 17.9 million deaths each year. The surge in geriatric populations, particularly in the developed nations, such a Japan, the U.S., and other major European nations, has augmented the demand for minimally invasive procedures, such as angioplasty. Elderly people are more prone to arterial blockages, that raise the need for advanced balloon catheters.
Furthermore, growing advancements in balloon technologies, including scoring and drug-coated balloons, have improved procedural success rates, further driving the market growth. Several other factors, such as increasing elderly demographic and surging cardiovascular conditions are substantially boosting the angioplasty balloons demand globally.
Restraints:
High Advanced Angioplasty Balloons and Procedures' Cost Hamper Market Growth.
The high cost associated with advanced angioplasty balloons and related medical procedures is a significant restraint on market expansion. Specialized products like drug-eluting balloons (DEBs) and cutting balloons, while highly effective, are considerably more expensive than conventional options. Furthermore, the whole angioplasty procedure, that largely involves hospitalization, diagnostic imaging, and post-procedure care, that can impose financial burden on patients, particularly in the low- and middle-income nations.
Limited healthcare reimbursement policies in developing economies further deter patients from opting for these treatments. Hospitals and clinics, especially in the rural areas, also face challenges while investing in the cutting-edge balloon technologies. As a result, in-spite of the proven advantages of angioplasty balloons, the factors related to cost continue to impede market penetration, particularly in emerging areas, where affordability is crucial concern.
Opportunities:
Surging Technological Advancements in Biodegradable Balloons and Drug-Eluting Provide Better Market Growth Opportunities
The surging number of technological innovations in biodegradable and drug-eluting angioplasty balloons is providing substantial growth opportunities for the market. Drug-eluting balloons (DEBs) are efficient in decreasing restenosis rates without any need or permanent implants, further providing significant clinical benefits. The biodegradable balloons that get dissolved naturally after delivering therapy, temporarily remove long-term complications related to the traditional devices.
Key players are heavily investing in the R&D to create next-generation balloons with improved drug delivery mechanisms, decreased side effects, and better vessel healing properties. Regulatory approvals for these novel therapies are substantially rising, especially in North America and Europe, further creating opportunities for larger adoption. In addition, the growing demand for minimally invasive an patient-friendly treatment solutions continues to increase, creating favorable conditions for the these advanced angioplasty balloons' commercialization and expansion globally.
Challenges:
Strict Compliance Requirements and Regulatory Approvals Challenges the Market Expansion
The rigorous regulatory framework leading to angioplasty balloons’ development, testing, and commercialization is challenging the market expansion. Regulatory bodies including the European Medicines Agency (EMA), the U.S. Food and Drug Administration (FDA), and several other national agencies require a complete clinical evidence for validating the efficacy and safety of these new devices. This leads to long approval timelines and substantially raises product development costs.
Additionally, continuous changes in regulatory policies including Europe’s Medical Device Regulation (MDR) have surged the compliance bar for producers, imposing continuous investments in the clinical trials and quality management systems. Startups, along with small to mid-sized firms usually struggle to cope with these high regulatory costs, which hinders innovation and delay their market entry. Due to this, strict regulatory pathways are continuously creating challenges for companies operating in the angioplasty balloon market.
By Product
In 2023, the normal balloon segment held the largest angioplasty balloons market share of approximately 54%, in 2023. The segment's expansion is driven by their large adoption in routine percutaneous transluminal coronary angioplasty (PTCA) procedures. These balloons are highly versatile, cost-effective, and easily available compared to specialized balloons, such as drug-eluting or cutting balloons. The simple design, effectiveness, and ease of use, and effectiveness in expanding the narrowed arteries making them a preferred choice for a wide range of cardiovascular interventions, particularly in the initial angioplasty cases.
Furthermore, in several healthcare settings, particularly in the developing nations, the affordability of normal balloons plays a critical role in their dominance, as patients and hospitals widely opt for cost-efficient solutions. In addition, the ongoing advancements for enhancing the performance and durability of normal balloons have increased their application in both peripheral and coronary artery disease treatments, boosting their strong position in the global market.
By Application
In 2023, the normal balloon segment held the largest angioplasty balloons market share of approximately 54%, in 2023. The segment's expansion is driven by their large adoption in routine percutaneous transluminal coronary angioplasty (PTCA) procedures. These balloons are highly versatile, cost-effective, and easily available compared to specialized balloons like drug-eluting or cutting balloons. The simple design, effectiveness, and ease of use, and effectiveness in expanding the narrowed arteries making them a preferred choice for a wide range of cardiovascular interventions, particularly in the initial angioplasty cases.
Furthermore, in several healthcare settings, particularly in the developing nations, the affordability of normal balloons plays a critical role in their dominance, as patients and hospitals widely opt for cost-efficient solutions. In addition, the ongoing advancements for enhancing the performance and durability of normal balloons have increased their application in both peripheral and coronary artery disease treatments, boosting their strong position in the global market.
By End-User
By end-user, the ambulatory surgical centers segment dominated the market in terms of share, which was approximately 48.67% in 2023. The ability of ambulatory to offer high-quality, cost-effective, and efficient cardiovascular procedures compared to traditional hospital settings. ASCs specialize in same-day, minimally invasive surgeries, such as angioplasty, which reduces the healthcare costs, along with making these centers highly preferable for patients seeking faster recovery times.
In addition, the surging trend toward outpatient care, backed by government programs and favorable reimbursement policies from insurers, has substantially augmented the number of angioplasty procedures performed at ASCs. These centers feature advanced medical technologies and skilled professionals that enable them provide specialized cardiac care without increasing hospital stays. The surging preference among patients and physicians for personalized care, decreased hospital-acquired infections, and convenience that further boosts the dominance of ASCs in the global market.
North America accounted for a 42% market share in 2023. The growth is attributed to its advanced healthcare infrastructure, strong leading medical device companies’ presence, and high innovative medical technologies adoption across the region. North America has a high prevalence of cardiovascular diseases due to the aging populations, surging obesity rates, and sedentary lifestyles that substantially raise the demand for angioplasty procedures. Moreover, favorable reimbursement policies, strong government initiatives, and increased healthcare spending that support early diagnosis and treatment of heart diseases have further boosted the market growth.
The U.S., is the country which is most benefited from continuous research and development investments and frequent product approvals by regulatory bodies, such as the U.S. FDA, are encouraging faster market penetration. Combined with the rising awareness about minimally invasive treatments among patients and healthcare providers, North America continues to dominate the global angioplasty balloon market.
Europe held a substantial market share. The region’s expansion is driven by its strong healthcare infrastructure, growing cardiovascular diseases prevalence, and the surge in the adoption of minimally invasive procedures across Europe. Countries, such as Germany, the U.K., and France, and the U.K. have experienced significant investments in healthcare technologies, which further promote the utilization of advanced angioplasty balloons for effective cardiac treatments.
In addition, increased government initiatives, widespread health insurance coverage, and surging awareness related to early diagnosis and preventive healthcare have propelled the procedural volumes. The emphasis of Europe on the clinical research and innovation, along with partnerships between medical device manufacturers and hospitals has propelled the adoption of next-generation angioplasty solutions. The aging population and rising incidence of lifestyle-related conditions, including hypertension and diabetes have further boosted the angioplasty procedures’ steady growth, further strengthening Europe’s strong position in the market globally.
Abbott Laboratories (NC Trek Coronary Dilatation Catheter, XIENCE Sierra)
AngioDynamics (AngioSculpt PTCA Scoring Balloon Catheter, NanoCross Elite)
B. Braun Melsungen AG (SeQuent Please NEO, Mustang PTCA Balloon Catheter)
Becton Dickinson (UltraScore Focused Force PTA Balloon, Lutonix 035 Drug Coated Balloon)
Biomerics (Balloon Catheter Components, Biomerics Advanced Balloon Technology)
BIOTRONIK Vertriebs GmbH & Co. KG (Pantera Lux Drug-Coated Balloon, Passeo-18 Biotronik)
Boston Scientific Corporation (EMERGE PTCA Balloon Catheter, AGENT Drug-Coated Balloon)
Cardinal Health (Wolverine Cutting Balloon, Aviator Plus Balloon Dilatation Catheter)
Cordis (Cardinal Health) (SABER PTA Balloon Catheter, Aviator 2 Balloon Dilatation Catheter)
CTK Biotech, Inc. (CTK Angioplasty Balloon, CTK PTCA Balloon Catheter)
Hexacath (Osorio Drug Eluting Balloon, Ocelot Balloon Catheter)
INFINITY Angioplasty Balloon (INFINITY Coronary Balloon, INFINITY Peripheral Balloon)
JOTEC GmbH (Balloon-Expandable Stent System E-Vita OPEN NEO, JOTEC PTA Balloon Catheter)
Koninklijke Philips N.V. (Stellarex Drug-Coated Balloon, AngioSculpt RX PTCA Scoring Balloon)
Medtronic Plc (IN. PACT Admiral Drug-Coated Balloon, NC Euphora Balloon Catheter)
MicroPort Scientific Corporation (FireMagic PTCA Balloon Catheter, MicroPort Coronary Balloon)
Nipro Medical Corporation (Nipro RENOVA PTCA Balloon Catheter, Nipro PTA Balloon Catheter)
Cook Medical (Advance 35LP Low Profile PTA Balloon Catheter, Advance Micro 14 Catheter)
Terumo Corporation (GlideAssist PTA Balloon Catheter, Tazuna PTCA Balloon)
Meril Life Sciences (VITESSE Drug-Coated Balloon, ABYSS PTCA Balloon Catheter)
In 2024, The U.S. FDA approved Boston Scientific Corporation’s AGENT Drug-Coated Balloon, specifically designed to treat coronary in-stent restenosis, further enhancing its portfolio of balloon catheter products.
In 2023, Abbott launched the Ultreon 1.0 Software, which is incorporated with Optical Coherence Tomography (OCT)-guided angioplasty systems, to optimize patient outcomes and improve the accuracy of balloon placement.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 2.66 Billion |
| Market Size by 2032 | USD3.58 Billion |
| CAGR | CAGR of3.36% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Production (Normal Balloons, Cutting/Scoring, Drug-Eluting) • By Application (Coronary Angioplasty, Peripheral Angioplasty) • By End-Users (Hospitals, Ambulatory Surgical Centers, Other) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG, Becton Dickinson, Biomerics, BIOTRONIK Vertriebs GmbH & Co. KG, Boston Scientific Corporation, Cardinal Health, Cordis, CTK Biotech, Inc, Hexacath, INFINITY Angioplasty Balloon, JOTEC GmbH, Koninklijke Philips N.V., Medtronic Plc, MicroPort Scientific Corporation, Nipro Medical Corporation, Cook Medical, Terumo Corporation, Meril Life Sciences |
Ans: The Angioplasty Balloon Market was valued at USD 2.66 Billion in 2023.
Ans: The expected CAGR of the global Angioplasty Balloon Market during the forecast period is 3.36%
Ans: Normal Balloons will grow rapidly in the Angioplasty Balloon Market from 2024-2032.
Ans: The Increasing prevalence of cardiovascular diseases and the rising geriatric population drive the angioplasty balloon market growth.
Ans: North America led the Angioplasty Balloon Market in the region with the highest revenue share in 2023.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Pricing Trends and Cost Analysis
5.2 Technology Adoption & Innovations
5.3 Regulatory & Compliance Statistics.
5.4 Healthcare Infrastructure Statistics
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Angioplasty Balloon Market Segmentation by Product
7.1 Chapter Overview
7.2 Normal Balloons
7.2.1 Normal Balloons Market Trends Analysis (2020-2032)
7.2.2 Normal Balloons Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Cutting/Scoring
7.3.1 Cutting/Scoring Market Trends Analysis (2020-2032)
7.3.2 Cutting/Scoring Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Drug-Eluting
7.3.1 Drug-Eluting Market Trends Analysis (2020-2032)
7.3.2 Drug-Eluting Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Angioplasty Balloon Market Segmentation By Application
8.1 Chapter Overview
8.2 Coronary Angioplasty
8.2.1 Coronary Angioplasty Market Trend Analysis (2020-2032)
8.2.2 Coronary Angioplasty Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Peripheral Angioplasty
8.3.1 Peripheral Angioplasty Market Trends Analysis (2020-2032)
8.3.2 Peripheral Angioplasty Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Angioplasty Balloon Market Segmentation By End-User
9.1 Chapter Overview
9.2 Hospitals
9.2.1 Hospitals Market Trends Analysis (2020-2032)
9.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Ambulatory Surgical Centers
9.3.1 Ambulatory Surgical Centers Market Trends Analysis (2020-2032)
9.3.2 Ambulatory Surgical Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Others
9.4.1 Others Market Trends Analysis (2020-2032)
9.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Angioplasty Balloon Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.4 North America Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.2.5 North America Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.6.2 USA Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.2.6.3 USA Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.7.2 Canada Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.2.7.3 Canada Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.8.2 Mexico Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.2.8.3 Mexico Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Angioplasty Balloon Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.6.2 Poland Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.6.3 Poland Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.7.2 Romania Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.7.3 Romania Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Angioplasty Balloon Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.4 Western Europe Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.5 Western Europe Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.6.2 Germany Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.6.3 Germany Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.7.2 France Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.7.3 France Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.8.2 UK Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.8.3 UK Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.9.2 Italy Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.9.3 Italy Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.10.2 Spain Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.10.3 Spain Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.13.2 Austria Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.13.3 Austria Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Angioplasty Balloon Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.4 Asia Pacific Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.5 Asia Pacific Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.6.2 China Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.6.3 China Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.7.2 India Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.7.3 India Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.8.2 Japan Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.8.3 Japan Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.9.2 South Korea Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.9.3 South Korea Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.10.2 Vietnam Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.10.3 Vietnam Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.11.2 Singapore Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.11.3 Singapore Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.12.2 Australia Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.12.3 Australia Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Angioplasty Balloon Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.4 Middle East Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.5 Middle East Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.6.2 UAE Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.6.3 UAE Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Angioplasty Balloon Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.4 Africa Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.2.5 Africa Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Angioplasty Balloon Market Estimates and Forecasts By Application (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Angioplasty Balloon Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.4 Latin America Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.5 Latin America Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.6.2 Brazil Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.6.3 Brazil Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.7.2 Argentina Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.7.3 Argentina Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.8.2 Colombia Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.8.3 Colombia Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Angioplasty Balloon Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Angioplasty Balloon Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Angioplasty Balloon Market Estimates and Forecasts, By End-User (2020-2032) (USD Billion)
11. Company Profiles
11.1 Abbott Laboratories
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Product/ Services Offered
11.1.4 SWOT Analysis
11.2 AngioDynamics
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Product/ Services Offered
11.2.4 SWOT Analysis
11.3 B. Braun Melsungen AG.
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Product/ Services Offered
11.3.4 SWOT Analysis
11.4 Becton Dickinson
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Product/ Services Offered
11.4.4 SWOT Analysis
11.5 Biomerics
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Product/ Services Offered
11.5.4 SWOT Analysis
11.6 BIOTRONIK Vertriebs GmbH & Co. KG
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Product/ Services Offered
11.6.4 SWOT Analysis
11.7 Boston Scientific Corporation
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Product/ Services Offered
11.7.4 SWOT Analysis
11.8 Cardinal Health
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Product/ Services Offered
11.8.4 SWOT Analysis
11.9 Cordis
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Product/ Services Offered
11.9.4 SWOT Analysis
11.10 CTK biotech, Inc
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Product/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Product
Normal Balloons
Cutting/Scoring
Drug-Eluting
By Application
Coronary Angioplasty
Peripheral Angioplasty
By End-Users
Hospitals
Ambulatory Surgical Centers
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Smart Fertility Tracker Market was valued at USD 0.17 billion in 2023, and is expected to reach USD 0.42 billion by 2032, and grow at a CAGR of 10.59% over the forecast period 2024-2032.
DNA Sequencing Market size was valued at USD 11.5 Billion in 2023 and is expected to reach USD 52.1 Billion by 2032, growing at a CAGR of 17.8% from 2024-2032.
Operating Room Management Market was valued at $ 2.18 billion in 2023 & is expected to reach $ 5.83 billion by 2032, growing at a CAGR of 11.56% from 2024-2032.
The Healthcare Digital Signage Market Size was USD 6.31 Billion in 2023 & is expected to reach USD 19.78 Bn by 2032 & grow at a CAGR of 13.58% by 2024-2032.
The global Biologics Market size valued at USD 433.77 billion in 2023, is projected to reach USD 977.36 billion by 2032, growing at 9.46% CAGR from 2024-2032.
The BOTOX market size was valued at USD 5.58 billion in 2023 and is projected to reach USD 13.74 billion by 2032, growing at a CAGR of 10.55% from 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
